3000+ Attendees, 450 Speakers, 12 Conference Tracks, 100+ Posters
MMTC M Header 
Cancer-Channel Icon 

Recently, the heterogeneity and complexity of malignant tumors has changed the way we think about the initiation, progression, diagnosis, and management of cancer. The Cancer Channel will explore the emerging molecular markers, improved preclinical models, and genomic-based therapies that are increasing the success of personalized medicine.

Circulating Tumor Cells

Predictive Preclinical Models in Oncology

Cancer Molecular Markers

Translational to Clinical R&D

Technology-Driven Oncology Clinical Development


You may also be interested in:


Gene Editing - New

Cancer Immunotherapy - New



  2015 Plenary Sessions 

2015 MMTC Prelim Agenda 

Premier Sponsors:


Jackson Laboratory - small logo 

Leica Biosystems